Regorafenib (Hydrochloride) (Standard)
Regorafenib (Hydrochloride) (Standard) is the analytical standard of Regorafenib (Hydrochloride) . This product is intended for research and analytical applications. Regorafenib Hydrochloride (BAY 73-4506 hydrochloride) is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively[1].
Product Specifications
CAS Number
835621-07-3
UNSPSC
12352100
Target
Autophagy; PDGFR; Raf; Reference Standards; RET; VEGFR
Related Pathways
Autophagy; MAPK/ERK Pathway; Others; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
ClC1=C(C(F)(F)F)C=C(NC(NC2=C(F)C=C(OC3=CC=NC(C(NC)=O)=C3)C=C2)=O)C=C1.Cl
Molecular Formula
C21H16Cl2F4N4O3
Molecular Weight
519.28
References & Citations
[1]Wilhelm SM, et al. Regorafenib (BAY 73-4506) : a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer, 2011, 129 (1), 245-255.|[2]Heng DY, et al. Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions. Ther Adv Med Oncol, 2010, 2 (1), 39-49.|[3]Carr BI, et al. Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery. J Cell Physiol, 2013, 228 (2), 292-297.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC433008 20 µg
PPAR delta (PPARD) (NM_001171819) Human Over-expression Lysate
Sign In for Pricing
View Details 
LC428611 20 µg
NEDD4 2 (NEDD4L) (NM_001144964) Human Over-expression Lysate
Sign In for Pricing
View Details 
1343-AAT 2 Labelings
Buccutite™ Rapid PE-Texas Red Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Sign In for Pricing
View Details